FindTrial
Sign In

â??COMPARING THREE DIFFERENT TREATMENT MODALITIES IN PATCHY HAIR LOSS â??

â??COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF INTRALESIONAL STEROID, TACROLIMUS (0.1%) OINTMENT AND MINOXIDIL (5%) IN THE TREATMENT OF ALOPECIA AREATAâ??

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/08/003880
Enrollment
60
Registered
2013-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with patchy hair loss

Interventions

Control Intervention1: â??COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF INTRALESIONAL STEROID, TACROLIMUS (0.1%) OINTMENT AND MINOXIDIL (5%) IN THE TREATMENT OF ALOPECIA AREATA: â??COMPARATIVE STUDY

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient willing for the study. 2.Patients with circumscribed patch of hair loss without scarring. 3.Patients who have not taken any treatment for alopecia areata during last six months. 4.Patients age more than 10 years.

Exclusion criteria

Exclusion criteria: 1.Patients not willing for study. 2.Patients having scarry alopecia. 3.Patients with secondary infection. 4.Patients with pregnancy and lactation. 5.Extensive lesions.

Design outcomes

Primary

MeasureTime frame
To evaluate safety and efficacy of three modalities of treatment in Alopecia Areata.Timepoint: 5—

Secondary

MeasureTime frame
To evaluate the safety and efficacy of Intralesional steroid,Tacrolimus(0.1%) ointment and Minoxidil(5%)in the treatment of Alopecia areata.Timepoint: 3rd, 6th,9th,12th wk—

Countries

India

Contacts

Public ContactDr Nanda kishore B

Father muller medical college

drnandakishoreb@rediffmail.com9343567927

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026